Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance.
Jesus JimenezNicolas KosteleckyJoshua D MitchellKathleen W ZhangChieh-Yu LinDaniel J LenihanKory J LavinePublished in: Cardio-oncology (London, England) (2023)
While the Dallas criteria can identify a subset of ICI-associated myocarditis patients, quantification of macrophage abundance may expand the diagnostic role of EMB. Failure to meet the traditional Dallas Criteria should not exclude the diagnosis of myocarditis.